Acoustophoresis Enables the Label‐Free Separation of Functionally Different Subsets of Cultured Bone Marrow Stromal Cells
Open Access
- 15 June 2020
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 99 (5) , 476-487
Abstract
Culture‐expanded mesenchymal stromal cells (MSCs) are promising candidates for clinical cell‐based therapies. MSC products are heterogeneous and we therefore investigated whether acoustophoresis, an ultrasound‐based separation technology, could be used for the label‐free enrichment of functionally different MSC populations. Acoustophoresis uses an ultrasonic standing wave field in a microchannel that differentially affects the movement of cells depending on their acoustophysical properties, such as size, density, and compressibility. Human bone marrow (BM) MSCs were generated by standard adherent culture in xeno‐free medium and separated by microchip acoustophoresis. MSCs with up to 20% higher proliferation and 1.7‐fold increased clonogenic potential were enriched in the side outlet of the chip compared to the input sample. These cells were significantly smaller (average diameter 14.5 ± 0.4 μm) compared to the center outlet fraction (average diameter 17.1 ± 0.6 μm) and expressed higher levels of genes related to proliferation and stem cell properties (i.e., Ki‐67 [1.9‐fold], Nanog1 [6.65‐fold], Oct4 [2.9‐fold], and CXCL12 [1.8‐fold], n = 3) in the side outlet compared to input. Fractions of MSCs in G0/G1 cell cycle phase were significantly enriched in the side fraction and an up to 2.8‐fold increase of cells in S/G2/M phases were observed in center fractions compared to side fractions and 1.3‐fold increased compared to the input sample. Acoustophoresis did not compromise MSC phenotype, proliferation, clonogenic capacity, and viability (generally 87–98%), nor did it affect differentiation or immunomodulatory capacities. These results demonstrate that label‐free acoustic separation can enrich functionally different MSC subsets which can potentially be employed to produce better‐defined stromal cell products from cultured MSCs. Hence, acoustophoresis is a potentially promising separation technology to provide improved cell products for research and possible future clinical use. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC. on behalf of International Society for Advancement of Cytometry.Keywords
Funding Information
- Barncancerfonden (BCF MT2015‐0020)
- Horizon 2020 Framework Programme (668724, 731377, 733006)
- Swedish Cancer Foundation (CAN 2012/1318)
- Vetenskapsrådet (2019‐00795)
- VINNOVA (CAMP Contract no. 2017‐02130)
This publication has 62 references indexed in Scilit:
- Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor CellsPLOS ONE, 2013
- Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC TherapiesPLOS ONE, 2013
- Acoustophoretic Sorting of Viable Mammalian Cells in a Microfluidic DeviceAnalytical Chemistry, 2012
- Emerging Clinical Applications of Microchip-Based AcoustophoresisSLAS Technology, 2011
- Efficient Removal of Platelets from Peripheral Blood Progenitor Cell Products Using a Novel Micro-Chip Based Acoustophoretic PlatformPLOS ONE, 2011
- CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localizationBlood, 2011
- Acoustophoretic Synchronization of Mammalian Cells in MicrochannelsAnalytical Chemistry, 2010
- Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone MarrowStem Cells, 2009
- Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cordCell Communication and Signaling, 2009
- Selection of mammalian cells based on their cell-cycle phase using dielectrophoresisProceedings of the National Academy of Sciences, 2007